Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Figure 1 | BMC Genetics

Figure 1

From: Fusion of the NUP98 gene with the LEDGF/p52 gene defines a recurrent acute myeloid leukemia translocation

Figure 1

RT-PCR analysis of NUP98-LEDGF expression. RT-PCR for the NUP98-LEDGF fusion was performed as outlined in the materials and methods. RNA samples are from peripheral blood mononuclear cells taken from a normal donor (lane 1), bone marrow mononuclear cells taken from t(9;11) patient presentation (lane 2), and peripheral blood mononuclear cells taken from t(9;11) patient remission (lane 3) and relapse (lane 4). Lane 5 is a relapse specimen negative control RT-PCR without reverse transcriptase. M is pUC19/HpaII molecular weight marker. The lower panel shows the corresponding PBGD PCR control reactions.

Back to article page

BMC Genomic Data

ISSN: 2730-6844

Contact us